Bavarian Nordic A/S (OTCMKTS:BVNRY) Share Price Crosses Below 200-Day Moving Average - Here's Why

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.84 and traded as low as $9.36. Bavarian Nordic A/S shares last traded at $9.39, with a volume of 7,157 shares changing hands.

Bavarian Nordic A/S Trading Up 1.0 %

The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of 21.34 and a beta of 1.71. The stock's fifty day simple moving average is $10.90 and its 200-day simple moving average is $9.84.

Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) last announced its quarterly earnings data on Thursday, August 22nd. The company reported $0.16 earnings per share (EPS) for the quarter. Bavarian Nordic A/S had a return on equity of 12.50% and a net margin of 11.50%. The business had revenue of $205.99 million for the quarter. On average, analysts anticipate that Bavarian Nordic A/S will post 0.57 EPS for the current fiscal year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.